CRISPR Therapeutics AG(CRSP)
Biotechnology
Gene Therapy & Gene Editing
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | Patel Naimish Chief Medical Officer | Sale | -3,786 | -16.36%19,357 | $55.62 | $210,577 | View SEC filing | |
| 2026-03-24 | KASINGER JAMES R. General Counsel and Secretary | Sale | -3,182 | -3.26%94,308 | $46.78 | $148,854 | View SEC filing | |
| 2026-03-24 | Kulkarni Samarth Chief Executive Officer | Sale | -10,020 | -3.77%255,501 | $46.78 | $468,736 | View SEC filing | |
| 2026-03-24 | Prasad Raju Chief Financial Officer | Sale | -3,708 | -19.24%15,565 | $46.78 | $173,460 | View SEC filing | |
| 2026-03-17 | Patel Naimish Chief Medical Officer | Sale | -3,150 | -19.33%13,143 | $48.26 | $152,019 | View SEC filing | |
| 2026-03-17 | Prasad Raju Chief Financial Officer | Sale | -9,869 | -41.74%13,773 | $48.26 | $476,278 | View SEC filing | |
| 2026-03-17 | KASINGER JAMES R. General Counsel and Secretary | Sale | -3,450 | -3.64%91,240 | $48.26 | $166,497 | View SEC filing | |
| 2026-03-17 | Kulkarni Samarth Chief Executive Officer | Sale | -10,349 | -4.04%245,834 | $48.26 | $499,443 | View SEC filing | |
| 2026-03-12 | KASINGER JAMES R. General Counsel and Secretary | Sale | -2,800 | -3.09%87,815 | $52.80 | $147,840 | View SEC filing | |
| 2026-03-12 | Kulkarni Samarth Chief Executive Officer | Sale | -9,798 | -3.99%235,558 | $52.80 | $517,334 | View SEC filing | |
| 2026-02-20 | Kulkarni Samarth Chief Executive Officer | Sale | -6,967 | -2.99%226,106 | $52.58 | $366,325 | View SEC filing | |
| 2026-02-20 | KASINGER JAMES R. General Counsel and Secretary | Sale | -2,112 | -2.42%85,115 | $52.58 | $111,049 | View SEC filing | |
| 2026-01-27 | Patel Naimish Chief Medical Officer | Purchase | +1,508 | +100.00%1,508 | $32.96 | $49,704 | View SEC filing | |
| 2026-01-26 | Prasad Raju Chief Financial Officer | Sale | -34,972 | -83.79%6,767 | $60.19 | $2,104,965 | View SEC filing | |
| 2026-01-22 | Kulkarni Samarth Chief Executive Officer | Sale | -90,000 | -40.14%134,201 | $57.40 | $5,166,298 | View SEC filing | |
| 2026-01-08 | Prasad Raju Chief Financial Officer | Sale | -29,700 | -81.44%6,767 | $60.16 | $1,786,636 | View SEC filing | |
| 2025-12-23 | Prasad Raju Chief Financial Officer | Sale | -10,000 | -59.64%6,767 | $55.95 | $559,549 | View SEC filing | |
| 2025-10-20 | Kulkarni Samarth Chief Executive Officer | Sale | -50,895 | -16.68%254,201 | $67.91 | $3,456,279 | View SEC filing | |
| 2025-10-15 | Kulkarni Samarth Chief Executive Officer | Sale | -4,242 | -2.03%205,096 | $66.60 | $282,517 | View SEC filing | |
| 2025-10-15 | KASINGER JAMES R. General Counsel and Secretary | Sale | -1,076 | -1.27%83,402 | $66.60 | $71,662 | View SEC filing | |
| 2025-08-19 | Kulkarni Samarth Chief Executive Officer | Sale | -13,081 | -5.94%207,004 | $58.15 | $760,660 | View SEC filing | |
| 2025-08-08 | Treco Douglas A Director | Purchase | +20,000 | +1000.00%22,000 | $57.03 | $1,140,600 | View SEC filing | |
| 2025-07-17 | George Simeon Director | Purchase | +989,812 | +94.36%2,038,763 | $52.03 | $51,499,918 | View SEC filing | |
| 2025-05-30 | Patel Naimish Chief Medical Officer | Sale | -3,932 | -39.32%6,068 | $35.94 | $141,316 | View SEC filing | |
| 2025-03-24 | Kulkarni Samarth Chief Executive Officer | Sale | -10,031 | -4.89%195,085 | $41.23 | $413,578 | View SEC filing |
1-25 of 206